Hochster hs et al. j clin oncol 2008 26:3523
NettetJ Clin Oncol 2008;26:5910-7. Hochster HS, Hart LL, Ramanathan RK, et al. Safety and Efficacy of Oxaliplatin and Fluoropyrimidine Regimens With or Without Bevacizumab As First-Line Treatment of Metastatic Colorectal Cancer: Results of the TREE Study. J Clin Oncol 2008;26:3523-9. Cite this article as: Fakih M. The International Duration ... Nettet10. okt. 2012 · Hochster HS ; Hart LL ; Ramanathan RK ; et al. ... J Clin Oncol. 2008; 26: 3523-3529. Crossref; PubMed; Scopus (506) Google Scholar; The incidence of grade 3 …
Hochster hs et al. j clin oncol 2008 26:3523
Did you know?
Nettet1. jul. 2008 · J Clin Oncol 18:2938,2000-2947, Goldberg RM, Sargent DJ, Morton RF, et al: A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin … Nettet10. jul. 2009 · In the experimental arm versus control arm, significantly less thrombocytopenia (1.4% v 3.4%, respectively) and fewer allergic reactions (3.1% v …
Nettet20. apr. 2008 · Patients and methods: Patients with MCRC were randomly assigned, in a 2 x 2 factorial design, to XELOX versus FOLFOX-4, and then to bevacizumab versus … Nettet23. jun. 2015 · J Clin Oncol. 2004;22:23–30. Article PubMed CAS Google Scholar Hochster HS, Hart LL, Ramanathan RK, et al. Safety and efficacy of oxaliplatin and fluoropyrimidine regimens with or without bevacizumab as first-line treatment of metastatic colorectal cancer: results of the TREE Study. J Clin Oncol. 2008;26:3523–9.
NettetJ Clin Oncol. 2007;25(30):4779–4786. 35. Hochster HS, Hart LL, Ramanathan RK, et al. Safety and efficacy of oxaliplatin and fluoropyrimidine regimens with or without bevacizumab as first-line treatment of metastatic colorectal cancer: results of the TREE Study. J Clin Oncol. 2008;26(21):3523–3529. 36. Nettet15. nov. 2012 · J Clin Oncol 2008 Apr 20; 26 (12): 2006–12 Article PubMed CAS Google Scholar Goldberg RM, Sargent DJ, Morton RF, et al. A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer. J Clin Oncol 2004 Jan 1; 22 (1): 23–30
Nettet10. mar. 2008 · Abstract. Purpose: We previously found that the risk of invasive breast cancer varied according to the progestagen component of combined postmenopausal …
Nettet12. mai 2010 · In the 57 patients assessed for response, the overall response rate was 72% (95% confidence interval, 58.5–83.0). Median progression-free survival was 11.0 months (95% confidence interval, 9.6–12.5) and median overall survival was 27.4 months (95% confidence interval, 22.0–not calculated). how to light a kettle bbqNettet20. aug. 2008 · Abstract. Purpose: The objective of this phase III global study was to compare the efficacy of gemcitabine plus paclitaxel (GT) versus paclitaxel in patients … how to light a kamado joe grillNettetJ Clin Oncol 2008; 26:3523. Maindrault-Goebel F, de Gramont A, Louvet C, et al. High-dose intensity oxaliplatin added to the simplified bimonthly leucovorin and 5-fluorouracil … how to light a led bulbNettet20. jul. 2008 · Safety and efficacy of oxaliplatin and fluoropyrimidine regimens with or without bevacizumab as first-line treatment of metastatic colorectal cancer: results of … josh mallory obituaryNettetJ Clin Oncol 26:3523-3529. © 2008 by American Society of Clinical Oncology INTRODUCTION Oxaliplatin-based therapy is standard first-line … josh malone us inventorNettet21. sep. 2016 · Supplements Abstract Purpose To evaluate the efficacy and safety of bevacizumab when added to first-line oxaliplatin-based chemotherapy (either capecitabine plus oxaliplatin [XELOX] or fluorouracil/folinic acid plus oxaliplatin [FOLFOX-4]) in patients with metastatic colorectal cancer (MCRC). Patients and Methods josh malone inventorNettet15. sep. 2012 · Hochster HS, Hart LL, Ramanathan RK, et al. Safety and efficacy of oxaliplatin and fluoropyrimidine regimens with or without bevacizumab as first-line treatment of metastatic colorectal cancer: results of the TREE study. J Clin Oncol 2008 Jul 20; 26(21): 3523–9. Article PubMed CAS Google Scholar josh malone nfl wikipedia